Home › Funds › Boxer Capital Management, LLC › PGEN
Boxer Capital Management, LLC position in PGEN
PRECIGEN INC · Health Care
Boxer Capital Management, LLC reported holding 5,150,000 shares of PGEN (PRECIGEN INC) in its Q2 2026 13F filing — a position valued at US$29.4M, representing 2.21% of its reported portfolio and ranking #12 among its reported holdings. Boxer Capital Management, LLC has disclosed PGEN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Boxer Capital Management, LLC's PGEN position evolved
Boxer Capital Management, LLC first disclosed a stake in PGEN in Q3 2025 at 850,000 shares (US$2.8M). The position peaked in Q2 2026 at 5,150,000 shares, worth US$29.4M. Across 4 filings, Boxer Capital Management, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 5,150,000 shares valued at US$29.4M — an increase of 1,650,000 shares quarter over quarter.. Notable position changes include a 62% increase in Q4 2025 (shares fell 7% over the following quarter), a 155% increase in Q1 2026 (shares rose 47% over the following quarter), a 47% increase in Q2 2026 (shares rose 50% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 850.00K | $2.80M | New |
| Q4 2025 | 1.38M | $5.75M | Add |
| Q1 2026 | 3.50M | $13.54M | Add |
| Q2 2026 | 5.15M | $29.36M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PGEN and 13F data
PGEN (PRECIGEN INC) is a Health Care company. 58 other funds we track also report a position in PGEN — the largest reported positions include Patient Capital Management, LLC (US$108.5M), TANG CAPITAL MANAGEMENT LLC (US$36.6M), IRIDIAN ASSET MANAGEMENT LLC/CT (US$23.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PGEN
- Patient Capital Management, LLC 19.04M sh · $108.51M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 6.42M sh · $36.58M · Q2 2026
- IRIDIAN ASSET MANAGEMENT LLC/CT 4.03M sh · $22.98M · Q2 2026
- Diametric Capital, LP 1.41M sh · $8.05M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 683.42K sh · $5.85M · Q3 2026
- LexAurum Advisors, LLC 633.53K sh · $5.42M · Q3 2026
- GMT CAPITAL CORP 668.83K sh · $3.81M · Q2 2026
- Lansing Street Advisors 495.42K sh · $2.82M · Q2 2026
- Occam Crest Management LP 35.50K sh · $2.49M · Q2 2026
More on Boxer Capital Management, LLC
FAQ
How long has Boxer Capital Management, LLC held PGEN?
Boxer Capital Management, LLC has disclosed PGEN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Boxer Capital Management, LLC's current position in PGEN?
As of Q2 2026, Boxer Capital Management, LLC holds 5.15M shares of PGEN (PRECIGEN INC), valued at $29.36M, representing 2.21% of its reported portfolio and ranking #12.
Has Boxer Capital Management, LLC been buying or selling PGEN?
In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC increased its position in PGEN. The position peaked in Q2 2026 at 5.15M shares.
Which other funds hold PGEN?
Other major institutional holders of PGEN include Patient Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.